Most clinical trials of semaglutide have focused on its efficacy in glycaemic control, cardiovascular outcomes and weight reduction, rather than sexual health endpoints
Prevalence of obesity and severe obesity among adults: United states, 2017-2018
Consulting your healthcare provider about any issues when it comes to sticking to the regimen can also help you find solutions
By stimulating insulin release and signaling fullness, tirzepatide helps people eat less and burn more sugar, leading to significant weight loss
This group of patients is particularly vulnerable due to severity of disease and length and multiple immunosuppressive agents [36]
Originally developed and positioned as treatments for type 2 diabetes, these agents are now equally associated with weight management, reshaping how clinicians, patients, and pharmacies understand metabolic disease